– CANADA, Toronto – Aura Health Inc. (CSE:BUZZ) today announced the appointment of Alain Dobkin to its board of directors, subject to regulatory approval.
To make room for Mr. Dobkin, Chris Carl has volunteered to step down as President and from Aura’s board to focus on his role as CEO of DigiCrypts.
Daniel Cohen, Aura’s CEO, commented, “Alain brings significant pedigree to Aura’s board of directors both from a financial perspective and a knowledge of Israeli and European markets. As we continue to build out our asset base in Israel and Europe, Alain being situated in Tel Aviv will be a tremendous asset to our business. We wish the best of luck to Chris in his new endeavor.”
About Alian Dobkin
Alain is a private equity investor with more than 20 years of investment and advisory experience, including 13 years with Citigroup Investment Bank in New York and Tel Aviv. Additionally, he was the Director of Citigroup’s Israel Investment Bank, where he served as advisor on strategic mergers and acquisitions and equity and debt capital raising transactions from both public and private markets globally. Alain brings a wealth of experience in global and Israeli finance and M&A having managed transactions with aggregate value of ~US$40 billion.
About Aura Health Inc.
Aura Health is building an international network of vertically integrated cannabis assets. There are some medical evidence of various malformations in the foetus which are organic heart disorders, deformities of the facial part of the skull if Klonopin uk at the http://www.thelaneshealthandbeauty.com/klonopin-online-uk/ was used in the early stages of pregnancy. Through a product line of cannabis-infused edible products and oil extracts, Aura is dedicated to building a high margin downstream business in the medical marijuana sector. The Company holds debt convertible into 54% equity of HolyCanna, a cultivation and nursery license holder in Israel. Aura has also entered into a definitive agreement to acquire 80% of Pharmadrug, a German medical cannabis and pharmaceutical distributor, as well as a binding letter of intent to purchase 57% of CannabiSendak, the builder of a network of high-profile dispensaries in Israel. The Company also owns a 30% interest in four medical marijuana clinics in the U.S. Sun Belt.
For more information : http://www.aurahealthclinics.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
